{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:21:49Z","timestamp":1762100509671,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.reprotox.2006.04.014","type":"journal-article","created":{"date-parts":[[2006,6,16]],"date-time":"2006-06-16T08:06:08Z","timestamp":1150445168000},"page":"688-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Reproductive screening test of feverfew"],"prefix":"10.1016","volume":"22","author":[{"given":"Mei","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen E.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia D.","family":"Brown-Woodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6495","key":"10.1016\/j.reprotox.2006.04.014_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.291.6495.569","article-title":"Efficacy of feverfew as prophylactic treatment of migraine","volume":"291","author":"Johnson","year":"1985","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"8604","key":"10.1016\/j.reprotox.2006.04.014_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(88)92289-1","article-title":"Randomised double-blind placebo-controlled trial of feverfew in migraine prevention","volume":"2","author":"Murphy","year":"1988","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.reprotox.2006.04.014_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1468-2982.2002.00396.x","article-title":"The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis\u2014a double-blind, multicentre, randomized placebo-controlled dose\u2013response study","volume":"22","author":"Pfaffenrath","year":"2002","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.reprotox.2006.04.014_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1468-2982.2005.00950.x","article-title":"Efficacy and safety of 6.25mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention a randomized, double-blind, multicentre, placebo-controlled study","volume":"25","author":"Diener","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/j.reprotox.2006.04.014_bib5","first-page":"26","article-title":"Feverfew","volume":"20","author":"Hobbs","year":"1989","journal-title":"Herbal Gram"},{"year":"1984","series-title":"Feverfew: a traditional herbal remedy for migraine and arthritis","author":"Johnson","key":"10.1016\/j.reprotox.2006.04.014_bib6"},{"issue":"4A","key":"10.1016\/j.reprotox.2006.04.014_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1017\/S1368980000000598","article-title":"The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review","volume":"3","author":"Ernst","year":"2000","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.reprotox.2006.04.014_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0079-6468(08)70009-2","article-title":"Progress in the medicinal chemistry of the herb feverfew","volume":"29","author":"Groenewegen","year":"1992","journal-title":"Prog Med Chem"},{"issue":"3","key":"10.1016\/j.reprotox.2006.04.014_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1039\/np9951200271","article-title":"Feverfew: chemistry and biological activity","volume":"12","author":"Knight","year":"1995","journal-title":"Nat Prod Rep"},{"issue":"6","key":"10.1016\/j.reprotox.2006.04.014_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.2042-7158.1987.tb03420.x","article-title":"Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups","volume":"39","author":"Heptinstall","year":"1987","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"10.1016\/j.reprotox.2006.04.014_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0049-3848(87)90383-5","article-title":"An extract of feverfew inhibits interactions of human platelets with collagen substrates","volume":"48","author":"Losche","year":"1987","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.reprotox.2006.04.014_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.2042-7158.1990.tb07057.x","article-title":"A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro","volume":"42","author":"Groenewegen","year":"1990","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.reprotox.2006.04.014_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1468-2982.2005.00915.x","article-title":"Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine","volume":"25","author":"Tassorelli","year":"2005","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.reprotox.2006.04.014_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.10159","article-title":"Nuclear factor-kappaB as a molecular target for migraine therapy","volume":"51","author":"Reuter","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.reprotox.2006.04.014_bib15","unstructured":"NHMRC, Australian code of practice for the care and use of animals for scientific purposes. Canberra: Australian Government, 7th ed; 2004."},{"key":"10.1016\/j.reprotox.2006.04.014_bib16","first-page":"311","article-title":"Effect of acute maternal ethanol exposure upon foetal development in the rat","volume":"7","author":"Samson","year":"1979","journal-title":"Phys Psych"},{"issue":"3","key":"10.1016\/j.reprotox.2006.04.014_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jmor.1051270303","article-title":"A rapid method for detecting malformations in rat fetuses","volume":"127","author":"Barrow","year":"1969","journal-title":"J Morphol"},{"year":"1986","series-title":"Practical teratology","author":"Taylor","key":"10.1016\/j.reprotox.2006.04.014_bib18"},{"issue":"234","key":"10.1016\/j.reprotox.2006.04.014_bib19","first-page":"63798","article-title":"Guidelines for developmental toxicity risk assessment","volume":"56","author":"U.S. Environmental Protection Agency","year":"1991","journal-title":"Federal Register"},{"key":"10.1016\/j.reprotox.2006.04.014_bib20","series-title":"The mammalian fetus in vitro","first-page":"15","article-title":"Studies on mammalian fetuses in vitro during the period of organogenesis","author":"New","year":"1973"},{"issue":"11","key":"10.1016\/j.reprotox.2006.04.014_bib21","first-page":"1649","article-title":"Cytotoxicity of sesquiterpene lactones","volume":"31","author":"Lee","year":"1971","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.reprotox.2006.04.014_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0026-895X(25)14544-6","article-title":"Inhibition of DNA replication in HeLa S3 cells by macromomycin-I, an antitumor protein antibiotic","volume":"18","author":"Woynarowski","year":"1980","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.reprotox.2006.04.014_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0026-895X(25)12543-1","article-title":"Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones","volume":"19","author":"Woynarowski","year":"1981","journal-title":"Mol Pharmacol"},{"issue":"10\u201311","key":"10.1016\/j.reprotox.2006.04.014_bib24","article-title":"Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets","volume":"47","author":"Loesche","year":"1988","journal-title":"Biomed Biochim Acta"},{"key":"10.1016\/j.reprotox.2006.04.014_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/jm00235a013","article-title":"Synthesis and cytotoxic activity of epoxides of helenalin related derivatives","volume":"18","author":"Lee","year":"1975","journal-title":"Med Chem"},{"key":"10.1016\/j.reprotox.2006.04.014_bib26","first-page":"865","article-title":"Antitumor agent, 21, A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones","volume":"67","author":"Hall","year":"1977","journal-title":"Pharmacol Soc"},{"issue":"5","key":"10.1016\/j.reprotox.2006.04.014_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.2042-7158.1992.tb03631.x","article-title":"Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products","volume":"44","author":"Heptinstall","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.reprotox.2006.04.014_bib28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1055\/s-2003-45147","article-title":"Transport of parthenolide across human intestinal cells (Caco-2)","volume":"69","author":"Khan","year":"2003","journal-title":"Planta Med"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089062380600102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089062380600102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:08Z","timestamp":1760189048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089062380600102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S089062380600102X"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2006.04.014","relation":{},"ISSN":["0890-6238"],"issn-type":[{"type":"print","value":"0890-6238"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Reproductive screening test of feverfew","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2006.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}